BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23458109)

  • 1. The effect of hepatic steatosis on survival following resection of colorectal liver metastases in patients without preoperative chemotherapy.
    Parkin E; O'Reilly DA; Adam R; Kaiser GM; Laurent C; Elias D; Capussotti L; Renehan AG;
    HPB (Oxford); 2013 Jun; 15(6):463-72. PubMed ID: 23458109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equivalent survival in patients with and without steatosis undergoing resection for colorectal liver metastases following pre-operative chemotherapy.
    Parkin E; O'Reilly DA; Adam R; Kaiser GM; Laurent C; Elias D; Capussotti L; Renehan AG;
    Eur J Surg Oncol; 2014 Nov; 40(11):1436-44. PubMed ID: 25189474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of steatosis on the short- and long-term results of resection of liver metastases from colorectal carcinoma.
    Ramos E; Torras J; Lladó L; Rafecas A; Serrano T; Lopez-Gordo S; Busquets J; Fabregat J
    HPB (Oxford); 2016 Apr; 18(4):389-96. PubMed ID: 27037210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of survival after liver resection for metastatic colorectal carcinoma.
    Parau A; Todor N; Vlad L
    J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management and Outcome of Colorectal Cancer Liver Metastases in Elderly Patients: A Population-Based Study.
    Booth CM; Nanji S; Wei X; Mackillop WJ
    JAMA Oncol; 2015 Nov; 1(8):1111-9. PubMed ID: 26355283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases.
    Pathak S; Tang JM; Terlizzo M; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2010 Jan; 36(1):52-7. PubMed ID: 19879103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity.
    Pilgrim CH; Satgunaseelan L; Pham A; Murray W; Link E; Smith M; Usatoff V; Evans PM; Banting S; Thomson BN; Phillips WA; Michael M
    HPB (Oxford); 2012 May; 14(5):333-40. PubMed ID: 22487071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome.
    Brouquet A; Abdalla EK; Kopetz S; Garrett CR; Overman MJ; Eng C; Andreou A; Loyer EM; Madoff DC; Curley SA; Vauthey JN
    J Clin Oncol; 2011 Mar; 29(8):1083-90. PubMed ID: 21263087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CALy Prognostic Score (CEA, ALP, Lymphocyte Count) as a predictor of survival after hepatectomy for liver-only colorectal metastases.
    Neofytou K; Giakoustidis A; Mudan S
    J BUON; 2015; 20(3):746-55. PubMed ID: 26214626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases.
    Devaud N; Kanji ZS; Dhani N; Grant RC; Shoushtari H; Serrano PE; Nanji S; Greig PD; McGilvray I; Moulton CA; Wei A; Gallinger S; Cleary SP
    HPB (Oxford); 2014 May; 16(5):475-80. PubMed ID: 23927606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of quantification of hepatic steatosis and future remnant volume in predicting hepatic dysfunction and complications after liver resection for colorectal metastases: a pilot study.
    Young AL; Wilson D; Ward J; Biglands J; Guthrie JA; Prasad KR; Toogood GJ; Robinson PJ; Lodge JP
    HPB (Oxford); 2012 Mar; 14(3):194-200. PubMed ID: 22321038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up.
    Pulitanò C; Castillo F; Aldrighetti L; Bodingbauer M; Parks RW; Ferla G; Wigmore SJ; Garden OJ
    HPB (Oxford); 2010 May; 12(4):244-9. PubMed ID: 20590894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeat liver resection for recurrent colorectal metastases: a single-centre, 13-year experience.
    Battula N; Tsapralis D; Mayer D; Isaac J; Muiesan P; Sutcliffe RP; Bramhall S; Mirza D; Marudanayagam R
    HPB (Oxford); 2014 Feb; 16(2):157-63. PubMed ID: 23530978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility, safety and efficacy of two-stage hepatectomy for bilobar liver metastases of colorectal cancer: a LiverMetSurvey analysis.
    Regimbeau JM; Cosse C; Kaiser G; Hubert C; Laurent C; Lapointe R; Isoniemi H; Adam R
    HPB (Oxford); 2017 May; 19(5):396-405. PubMed ID: 28343889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term results of extended left hepatectomy for colorectal metastases.
    Wicherts DA; de Haas RJ; Andreani P; Ariche A; Salloum C; Pascal G; Castaing D; Adam R; Azoulay D
    HPB (Oxford); 2011 Aug; 13(8):536-43. PubMed ID: 21762296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative Aspartate Aminotransferase-to-Platelet Ratio Index Predicts Perioperative Liver-Related Complications Following Liver Resection for Colorectal Cancer Metastases.
    Amptoulach S; Gross G; Sturesson C; Rissler P; Kalaitzakis E
    Scand J Surg; 2017 Dec; 106(4):311-317. PubMed ID: 28737112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic atrophy following preoperative chemotherapy predicts hepatic insufficiency after resection of colorectal liver metastases.
    Yamashita S; Shindoh J; Mizuno T; Chun YS; Conrad C; Aloia TA; Vauthey JN
    J Hepatol; 2017 Jul; 67(1):56-64. PubMed ID: 28192187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go?
    Ihnát P; Vávra P; Zonča P
    World J Gastroenterol; 2015 Jun; 21(22):7014-21. PubMed ID: 26078580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
    Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
    Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.